Sakura Finetek

Sakura Finetek USA is a privately-held, revenue-generating company specializing in diagnostic laboratory automation and equipment for histopathology. Founded in 1998, it has established itself as a market leader by providing integrated systems for tissue processing, staining, coverslipping, and imaging, emphasizing reliability and consistent, high-quality results. The company employs over 200 people in the U.S., operates globally through subsidiaries and distributors, and supports the market with a strong educational program. Its business model is centered on the sale of instruments, reagents, and consumables to clinical and research laboratories.

Integrated workflow automation for histopathology, including tissue processing, embedding, microtomy, staining (H&E, IHC, CISH, IF), coverslipping, specimen tracking, and digital slide imaging.

Competes in the anatomic pathology equipment market against major players like Roche (Ventana), Danaher (Leica Biosystems), and Agilent. Differentiation is achieved through a focus on total workflow integration, instrument reliability (highlighted MTBR), and a strong educational support program for customers.